---
title: "P3 Health Partners Inc. (PIII.US)"
type: "Symbol"
locale: "en"
url: "https://longbridge.com/en/quote/PIII.US.md"
symbol: "PIII.US"
name: "P3 Health Partners Inc."
industry: "Health Care Services"
datetime: "2026-05-19T23:44:11.410Z"
locales:
  - [en](https://longbridge.com/en/quote/PIII.US.md)
  - [zh-CN](https://longbridge.com/zh-CN/quote/PIII.US.md)
  - [zh-HK](https://longbridge.com/zh-HK/quote/PIII.US.md)
---

# P3 Health Partners Inc. (PIII.US)

## Company Overview

P3 Health Partners Inc., a patient-centered and physician-led population health management company, provides superior care services in the United States. It operates clinics and wellness centers. The company was founded in 2020 and is based in Henderson, Nevada.

| Item | Detail |
|------|--------|
| Industry | Health Care Services |
| Exchange | US Market |
| Website | [3hp.org](https://3hp.org) |

## Key Drivers
> *AI-analyzed key factors driving this stock's performance*


## Longbridge Financial Score™: C
> *Longbridge Financial Score™ — Proprietary multi-factor rating model by Longbridge*
> Updated: 2026-05-19T04:30:14.000Z

**Overall: C (0.51)**

**Industry**: Health Care Services

| Metric | Value |
|--------|-------|
| Industry Ranking | 54 / 87 |
| Industry Median | C |
| Industry Average | C |

- **Style**: Value - Stocks where the company's main business is in a mature stage.
- **Scale**: Small - The company's operation has a high degree of growth and volatility, making it easy to achieve high investment returns.

**Multi Score**: C

#### Style Score Score: 

| Indicator | Value | Rating |
|-----------|-------|--------|
| Revenue YoY | -0.87% |  |
| Net Profit YoY | 8.27% |  |
| P/B Ratio | -0.46 |  |
| Dividend Ratio | 0.00% |  |

#### Size Score Score: 

| Indicator | Value | Rating |
|-----------|-------|--------|
| Market Cap | 66147006.38 |  |
| Revenue | 1472245000.00 |  |

#### Multi Score Score: C

| Indicator | Value | Rating |
|-----------|-------|--------|
| ROE | 309.20% | A |
| Profit Margin | -8.57% | D |
| Gross Margin | 13.04% | D |
| Revenue YoY | -0.87% | D |
| Net Profit YoY | 8.27% | C |
| Total Assets YoY | -14.00% | E |
| Net Assets YoY | -209.98% | E |
| Cash Flow Margin | 67.52% | C |
| OCF YoY | -0.87% | D |
| Turnover | 2.02 | A |
| Gearing Ratio | 119.75% | E |

```chart-data:radar
{
  "title": "Longbridge Financial Score - P3 Health Partners Inc.",
  "chart_type": "radar",
  "dimensions": [
    {
      "name": "Style Score",
      "grade": "",
      "indicators": [
        {
          "name": "Revenue YoY",
          "value": "-0.87%",
          "rating": ""
        },
        {
          "name": "Net Profit YoY",
          "value": "8.27%",
          "rating": ""
        },
        {
          "name": "P/B Ratio",
          "value": "-0.46",
          "rating": ""
        },
        {
          "name": "Dividend Ratio",
          "value": "0.00%",
          "rating": ""
        }
      ]
    },
    {
      "name": "Size Score",
      "grade": "",
      "indicators": [
        {
          "name": "Market Cap",
          "value": "66147006.38",
          "rating": ""
        },
        {
          "name": "Revenue",
          "value": "1472245000.00",
          "rating": ""
        }
      ]
    },
    {
      "name": "Multi Score",
      "grade": "C",
      "indicators": [
        {
          "name": "ROE",
          "value": "309.20%",
          "rating": "A"
        },
        {
          "name": "Profit Margin",
          "value": "-8.57%",
          "rating": "D"
        },
        {
          "name": "Gross Margin",
          "value": "13.04%",
          "rating": "D"
        },
        {
          "name": "Revenue YoY",
          "value": "-0.87%",
          "rating": "D"
        },
        {
          "name": "Net Profit YoY",
          "value": "8.27%",
          "rating": "C"
        },
        {
          "name": "Total Assets YoY",
          "value": "-14.00%",
          "rating": "E"
        },
        {
          "name": "Net Assets YoY",
          "value": "-209.98%",
          "rating": "E"
        },
        {
          "name": "Cash Flow Margin",
          "value": "67.52%",
          "rating": "C"
        },
        {
          "name": "OCF YoY",
          "value": "-0.87%",
          "rating": "D"
        },
        {
          "name": "Turnover",
          "value": "2.02",
          "rating": "A"
        },
        {
          "name": "Gearing Ratio",
          "value": "119.75%",
          "rating": "E"
        }
      ]
    }
  ]
}
```

## Valuation Analysis

| Metric | Current | Industry Ranking | High | Median | Low |
|--------|---------|-----------------|------|--------|-----|
| PE (TTM) | -0.52 | 37/87 | - | - | - |
| PB | -0.46 | 60/87 | 1.16 | 0.73 | 0.65 |
| PS (TTM) | 0.04 | 4/87 | 0.03 | 0.02 | 0.01 |
| Dividend Yield | 0.00% | - | - | - | - |

## Peer Comparison

| Rank | Name | Profit | Growth | Operation | Security | Cash | Rating |
| --- | --- | --- | --- | --- | --- | --- | --- |
| 01 | Cigna (CI.US) | B | C | A | D | B | B |
| 02 | BrightSpring Health Services - Unit (BTSGU.US) | C | A | A | D | B | B |
| 03 | Fresenius (FSNUY.US) | C | B | C | C | B | B |
| 04 | Quest Diagnostics (DGX.US) | B | B | B | C | B | B |
| 05 | Labcorp (LH.US) | B | B | B | C | B | B |

## Institutional View

### Analyst Rating Distribution

> As of 2026-05-15T04:00:00.000Z

Total Analysts: **2**

| Rating | Count | Percentage |
|--------|-------|-----------| 
| Buy | 1 | 50% |
| Hold | 1 | 50% |

### Target Price Forecast

| Metric | Price |
|--------|-------|
| Current Price | 10.49 |
| Highest Target | 14.00 |
| Lowest Target | 3.00 |

## References

- [Company Overview — Profile, executives, shareholders, business breakdown](https://longbridge.com/en/quote/PIII.US/overview.md)
- [Financial Reports — Income, balance sheet, cash flow, dividends](https://longbridge.com/en/quote/PIII.US/norm.md)
- [Related News](https://longbridge.com/en/quote/PIII.US/news.md)
- [Filings — Company announcements and regulatory filings](https://longbridge.com/en/quote/PIII.US/filings.md)

---

> **Disclaimer: This article is for reference only and does not constitute any investment advice.**